Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Stemline Therapeutics Inc (NASDAQ:STML)

10.73
Delayed Data
As of Jul 31
 +0.14 / +1.32%
Today’s Change
10.26
Today|||52-Week Range
18.94
-37.10%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Hoberman Kenneth
Chief Operating Officer
Sale3/19/201517,307$16.43$284.4K-33.68%
Bergstein Ivan
Chief Executive Officer
Sale11/26/201411,974$14.40$172.4K-27.45%
Hoberman Kenneth
Chief Operating Officer
Buy3/19/201527,105$4.09$110.9K-33.68%
Gionco David G
Chief Accounting Officer
Sale1/20/20153,311$14.22$47.1K-24.81%
Bergstein Ivan
Chief Executive Officer
Sale2/18/20153,180$14.02$44.6K-23.79%
Rowinsky Eric K
Chief Medical Officer
Sale2/18/20151,640$13.99$22.9K-23.79%
Bentsur Ronald
Director
Sale3/18/20151,388$16.12$22.4K-32.64%
Hoberman Kenneth
Chief Operating Officer
Sale2/18/20151,593$14.02$22.3K-23.79%
Bentsur Ronald
Director
Buy3/18/20155,421$4.09$22.2K-32.64%
Bergstein Ivan
Chief Executive Officer
Buy9/03/20142,000$11.05$22.1K-1.74%
Page of 3